Cargando…

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022

The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess COVID-19 booster dose vaccination coverage am...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Peng-jun, Srivastav, Anup, Vashist, Kushagra, Black, Carla L., Kriss, Jennifer L., Hung, Mei-Chuan, Meng, Lu, Zhou, Tianyi, Yankey, David, Masters, Nina B., Fast, Hannah E., Razzaghi, Hilda, Singleton, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796208/
https://www.ncbi.nlm.nih.gov/pubmed/36480674
http://dx.doi.org/10.3201/eid2901.221151
_version_ 1784860430852685824
author Lu, Peng-jun
Srivastav, Anup
Vashist, Kushagra
Black, Carla L.
Kriss, Jennifer L.
Hung, Mei-Chuan
Meng, Lu
Zhou, Tianyi
Yankey, David
Masters, Nina B.
Fast, Hannah E.
Razzaghi, Hilda
Singleton, James A.
author_facet Lu, Peng-jun
Srivastav, Anup
Vashist, Kushagra
Black, Carla L.
Kriss, Jennifer L.
Hung, Mei-Chuan
Meng, Lu
Zhou, Tianyi
Yankey, David
Masters, Nina B.
Fast, Hannah E.
Razzaghi, Hilda
Singleton, James A.
author_sort Lu, Peng-jun
collection PubMed
description The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess COVID-19 booster dose vaccination coverage among adults. We used multivariable logistic regression analysis to assess factors associated with vaccination. COVID-19 booster dose coverage among fully vaccinated adults increased from 25.7% in November 2021 to 63.4% in March 2022. Coverage was lower among non-Hispanic Black (52.7%), and Hispanic (55.5%) than non-Hispanic White adults (67.7%). Coverage was 67.4% among essential healthcare personnel, 62.2% among adults who had a disability, and 69.9% among adults who had medical conditions. Booster dose coverage was not optimal, and disparities by race/ethnicity and other factors are apparent in coverage uptake. Tailored strategies are needed to educate the public and reduce disparities in COVID-19 vaccination coverage.
format Online
Article
Text
id pubmed-9796208
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-97962082023-01-09 COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 Lu, Peng-jun Srivastav, Anup Vashist, Kushagra Black, Carla L. Kriss, Jennifer L. Hung, Mei-Chuan Meng, Lu Zhou, Tianyi Yankey, David Masters, Nina B. Fast, Hannah E. Razzaghi, Hilda Singleton, James A. Emerg Infect Dis Research The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess COVID-19 booster dose vaccination coverage among adults. We used multivariable logistic regression analysis to assess factors associated with vaccination. COVID-19 booster dose coverage among fully vaccinated adults increased from 25.7% in November 2021 to 63.4% in March 2022. Coverage was lower among non-Hispanic Black (52.7%), and Hispanic (55.5%) than non-Hispanic White adults (67.7%). Coverage was 67.4% among essential healthcare personnel, 62.2% among adults who had a disability, and 69.9% among adults who had medical conditions. Booster dose coverage was not optimal, and disparities by race/ethnicity and other factors are apparent in coverage uptake. Tailored strategies are needed to educate the public and reduce disparities in COVID-19 vaccination coverage. Centers for Disease Control and Prevention 2023-01 /pmc/articles/PMC9796208/ /pubmed/36480674 http://dx.doi.org/10.3201/eid2901.221151 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Lu, Peng-jun
Srivastav, Anup
Vashist, Kushagra
Black, Carla L.
Kriss, Jennifer L.
Hung, Mei-Chuan
Meng, Lu
Zhou, Tianyi
Yankey, David
Masters, Nina B.
Fast, Hannah E.
Razzaghi, Hilda
Singleton, James A.
COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
title COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
title_full COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
title_fullStr COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
title_full_unstemmed COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
title_short COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
title_sort covid-19 booster dose vaccination coverage and factors associated with booster vaccination among adults, united states, march 2022
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796208/
https://www.ncbi.nlm.nih.gov/pubmed/36480674
http://dx.doi.org/10.3201/eid2901.221151
work_keys_str_mv AT lupengjun covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT srivastavanup covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT vashistkushagra covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT blackcarlal covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT krissjenniferl covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT hungmeichuan covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT menglu covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT zhoutianyi covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT yankeydavid covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT mastersninab covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT fasthannahe covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT razzaghihilda covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022
AT singletonjamesa covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022